CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD

Organization

Chengdu, Sichuan, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method for treating angiogenic eye disorders using VEGF antagonists
- Patent number 11,944,663
- Issue date Apr 2, 2024
- Chengdu Kanghong Biotechnologies Co. Ltd.
- Zunhong Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion protein inhibiting angiogenesis or growth and use thereof
- Patent number 9,657,084
- Issue date May 23, 2017
- Chengdu Kanghong Biotechnologies Co., LTD.
- Xiao Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) th...
- Patent number 9,096,669
- Issue date Aug 4, 2015
- Chengdu Kanghong Biotechnologies Co., Ltd.
- Xiao Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of neovascularization with a soluble chimeric protein co...
- Patent number 8,216,575
- Issue date Jul 10, 2012
- Chengdu Kanghong Biotechnologies Co., Ltd.
- Michael Dechao Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Construction of oncolytic adenovirus recombinant specifically expre...
- Patent number 7,951,585
- Issue date May 31, 2011
- Chengdu Kanghong Biotechnologies Co., Ltd.
- Zunhong Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Angiogenesis-inhibiting chimeric protein and the use
- Patent number 7,750,138
- Issue date Jul 6, 2010
- Chengdu Kanghong Biotechnologies Co. Ltd.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Method For Treating Angiogenic Eye Disorders Using Vegf Antagonists
- Publication number 20210393738
- Publication date Dec 23, 2021
- CHENGDU KANGHONG BIOTECHNOLOGIES CO. LTD.
- Zunhong Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN INHIBITING ANGIOGENESIS OR GROWTH AND USE THEREOF
- Publication number 20170002056
- Publication date Jan 5, 2017
- CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD
- Xiao Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-TNF-alpha Antibody and Antigen-Binding Fragment (Fab...
- Publication number 20140086904
- Publication date Mar 27, 2014
- Chengdu Kanghong Biotechnologies, Co., Ltd.
- Xiao Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of neovascularization with a soluble chimeric protein co...
- Publication number 20100272719
- Publication date Oct 28, 2010
- CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD.
- Michael Dechao Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANGIOGENESIS-INHIBITING CHIMERIC PROTEINS AND THE USE
- Publication number 20100215655
- Publication date Aug 26, 2010
- CHENGDU KANGHONG BIOTECHNOLOGIES CO. LTD.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Construction of oncolytic adenovirus recombinant specifically expre...
- Publication number 20100047208
- Publication date Feb 25, 2010
- CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD
- Zunhong Ke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF RECEPTOR FUSION PROTEINS, THEIR PHARMACEUTICAL COMPOSITIONS AN...
- Publication number 20090264358
- Publication date Oct 22, 2009
- CHENGDU KANGHONG BIOTECHNOLOGIES, CO., LTD
- Michael Dechao Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD

Organization

Patents Grantslast 30 patents

Method for treating angiogenic eye disorders using VEGF antagonists

Fusion protein inhibiting angiogenesis or growth and use thereof

Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) th...

Inhibition of neovascularization with a soluble chimeric protein co...

Construction of oncolytic adenovirus recombinant specifically expre...

Angiogenesis-inhibiting chimeric protein and the use

Patents Applicationslast 30 patents

Method For Treating Angiogenic Eye Disorders Using Vegf Antagonists

FUSION PROTEIN INHIBITING ANGIOGENESIS OR GROWTH AND USE THEREOF

Humanized Anti-TNF-alpha Antibody and Antigen-Binding Fragment (Fab...

Inhibition of neovascularization with a soluble chimeric protein co...

ANGIOGENESIS-INHIBITING CHIMERIC PROTEINS AND THE USE

Construction of oncolytic adenovirus recombinant specifically expre...

VEGF RECEPTOR FUSION PROTEINS, THEIR PHARMACEUTICAL COMPOSITIONS AN...